Barclays lowered the firm’s price target on Clorox to $115 from $118 and keeps an Underweight rating on the shares. The analyst thinks Clorox’s guidance “once again tees up the beat/raise debate,” though the firm sees the outlook as “prudent given the uncertainty ahead.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CLX: